The new instrument will be used in biologic medicine manufacturing, and will be developed by TTP as part of a new project led by Camena Bioscience and co-funded by Innovate UK.

Daiichi Sankyo and Takeda Pharmaceuticals to leverage FDA-approved test for clinical trials and drug development programs.

Point-of-care test for detection of infection in patients on peritoneal dialysis available in France, Germany, Italy, The Netherlands, Austria and Switzerland.

Protein Metrics Inc., a leading provider of mass spectrometry software for protein characterization, has introduced the Byos™ platform, which automates biotherapeutic characterization workflows with just one click.

Comprehensive registration system offers new capabilities that enhance intellectual property protection and supports emerging methodologies in biologic drug discovery.

Oppilotech Ltd, a biopharmaceutical company founded to develop safe, first-in-class, antibacterial therapies, announced it has been selected for funding by Innovate UK – the UK’s innovation agency.

Stronger strategic investments for further sustainable growth.

Porvair Sciences has collaborated with Persomics Inc. (Waltham, MA, USA) to develop and supply ANSI/SLAS format Arrays as an OEM product for their ImagineArray™ platform.

Synpromics Ltd, the leader in gene control, announces a partnership with Lonza Pharma & Biotech to further develop its inducible promoter system and improve manufacturing of biopharmaceuticals. The 18-month project has been made possible through the award of a £235,000 grant, part of the medicines manufacturing competition from Innovate UK.

Technology will be used to progress Fusion’s pipeline of alpha therapeutics for the treatment of cancers.